P2RY12 and coronary artery disorder: According to the ACC/AHA guidelines, discontinuation of aspirin may be considered 1–3 months after DES implantation with continued P2Y12 monotherapy in both stable ischemic heart disease (SIHD) and ACS patients (class 2a recommendation) (20).